Govt Job: For Pharmacist in Drug De-Addiction Centre at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Pharmacist

Applications are invited from the eligible candidates for filling up 1 post of Pharmacist. The detail of post and eligibility / criteria for filling up the said post is given as under.

Age : Up to 30 years

Emoluments : As per D.C Rate of Chandigarh Administration presently Rs 23,393/-

Qualifications :
Essentials:
1. Senior Secondary with Science or its equivalent from a recognised University/Board.

II. Degree in Pharmacy from a recognized institution/university.

III. Should be a registered Pharmacist under the Pharmacy Act 1948.
Desirable :

1. One year experience in dispensing and/or storage and dispensing of drugs in a reputed hospital or Institute or in a drug store of a pharmaceutical concern.

The applicants are required to submit their Bio-data (with self-attested photo copies of all the supporting documents & one photograph) by in the office of Drug De-addiction & Treatment Centre, PGIMER, Chandigarh.

And to be appeared for personal interview along with original certificate on 10/03/2022 at 9:30 am in Drug De-Addiction & Treatment Centre, PGIMER, Chandigarh.

If large numbers of applications are received a written test will be conducted.

No separate interview letters will be sent. No TA/DA will be paid.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework